BCL2 and ischemic stroke: In addition, the injection of IL-17A-neutralizing mAb could significantly increase Bcl-2 expression levels (Figure 3E, p = 0.0414, n = 6 per group), but decrease the expression levels of Bax (Figure 3F, p < 0.01, n = 6 per group) in the peri-infarct region of mice with ischemic stroke.